High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients With ROS1-Positive Metastatic Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2016.08.137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2018English

Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.13-27 Clinical Outcomes of Patients With Lung Adenocarcinoma Harboring Concomitant Driver Mutations in a Brazilian Cancer Center

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P075 Hippo-Yap Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prevalence of Epidermal Growth Factor Mutations in Patients With Non-Small Cell Lung Cancer in Turkish Population

Balkan Medical Journal
Medicine
2017English

Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients

Asian Pacific Journal of Cancer Prevention
2019English

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy